Candel Therapeutics, Inc.(CADL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CADL Candel Therapeutics, Inc.

Market Closed 09-04 16:00:00 EDT

12.78

-0.19

-1.46%

盘后12.76

-0.02-0.16%

19:46 EDT

High13.05	Low12.76	Vol535.72K
Open12.91	D1 Closing12.97	Amplitude2.24%
Mkt Cap977.91M	Tradable Cap767.53M	Total Shares76.52M
T/O6.90M	T/O Rate0.89%	Tradable Shares60.06M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CADL","market":"US","secType":"STK","nameCN":"Candel Therapeutics, Inc.","latestPrice":12.78,"timestamp":1788552000000,"preClose":12.97,"halted":0,"volume":535716,"hourTrading":{"tag":"盘后","latestPrice":12.76,"preClose":12.78,"latestTime":"19:46 EDT","volume":8193,"amount":104703.2545,"timestamp":1788565565053,"change":-0.02,"changeRate":-0.001565,"amplitude":0.001565},"delay":0,"changeRate":-0.014649190439475811,"floatShares":60056800,"shares":76518600,"eps":-1.438968,"marketStatus":"Market Closed","change":-0.19,"latestTime":"09-04 16:00:00 EDT","open":12.91,"high":13.05,"low":12.76,"amount":6900253.509312,"amplitude":0.022359,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.438968,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":7,"adr":0,"listingDate":1627358400000,"exchange":"NASDAQ","adjPreClose":12.97,"preHourTrading":{"tag":"盘前","latestPrice":12.91,"preClose":12.97,"latestTime":"09:29 EDT","volume":458,"amount":5915.95623,"timestamp":1788528599999,"change":-0.06,"changeRate":-0.004626,"amplitude":0.027926},"postHourTrading":{"tag":"盘后","latestPrice":12.76,"preClose":12.78,"latestTime":"19:46 EDT","volume":8193,"amount":104703.2545,"timestamp":1788565565053,"change":-0.02,"changeRate":-0.001565,"amplitude":0.001565},"volumeRatio":0.5949240120174669,"impliedVol":0.608,"impliedVolPercentile":0.2024},"requestUrl":"/m/hq/s/CADL","defaultTab":"news","newsList":[{"id":"2664866214","title":"Candel Therapeutics Grants 31,400 Inducement Stock Options at $13.07 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2664866214","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664866214?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:08","pubTimestamp":1788293334,"startTime":"0","endTime":"0","summary":"Candel Therapeutics grants 31,400 inducement stock options at $13.07 per shareCandel Therapeutics granted stock options for 31,400 shares to two new employees on Aug. 31, 2026.Exercise price set at US","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDLMczgd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BQXX3F31.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BKPKM429.USD","BCDF","BK4585","IE00B3QW5Z07.USD","BK4139","LU2095319765.USD","IE00BN0W2V16.EUR","CADL","BK4588","SG9999014005.SGD","SG9999014039.USD","SG9999014021.USD","LU2210150020.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","LU2210149790.SGD","NDAQ","LU0314104364.USD","IE00BQXX3D17.EUR","IE00BQXX3C00.GBP","BK4539","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664886645","title":"Candel Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664886645","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664886645?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:05","pubTimestamp":1788293101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nTUABDGZLY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","CADL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664241869","title":"Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664241869","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664241869?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:05","pubTimestamp":1788293100,"startTime":"0","endTime":"0","summary":"NEEDHAM, Mass., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immuno","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354586/0/en/candel-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","CADL","LCLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662013716","title":"Candel Therapeutics CEO to Speak at Citi Biopharma Back to School Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2662013716","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662013716?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:06","pubTimestamp":1787746009,"startTime":"0","endTime":"0","summary":"Candel Therapeutics CEO to speak at Citi Biopharma Back to School conference fireside chatCandel Therapeutics will join three New York investor conferences in September 2026, featuring analyst-led fir","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL83zf96:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130517989.USD","IE00BN0W2W23.USD","LU1144417596.USD","IE00BN0W2T93.GBP","IYF","IE00BQXX3D17.EUR","BK4207","LU0128525689.USD","LU1267930227.SGD","IE00BKPKM429.USD","SG9999014005.SGD","SG9999014013.SGD","BCDF","IE00BN0W2V16.EUR","NDAQ","LU1668664300.SGD","LU2417539215.USD","IE00B3QW5Z07.USD","LU1201861249.SGD","BK4566","LU0314106906.USD","LU2095319765.USD","LU2210150020.SGD","LU0314104364.USD","LU0477156953.USD","LU0072461881.USD","LU1244550221.USD","SG9999014039.USD","FTXO","LU0130102774.USD","LU2125154935.USD","LU0052756011.USD","LU2462157665.USD","IE00B64PRP62.GBP","LU2210149790.SGD","CADL","SG9999014021.USD","LU1506573853.SGD","TFNS","BK4534","LU0162691827.USD","LU2360032135.SGD","BK4139","BK4539","LU0098860793.USD","BK4504","LU0203345920.USD","LU0320765646.SGD","LU0106831901.USD","LU0203347892.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662874719","title":"Candel Therapeutics to Present at September Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2662874719","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662874719?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:05","pubTimestamp":1787745900,"startTime":"0","endTime":"0","summary":"NEEDHAM, Mass., Aug.  26, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunot","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/26/3351310/0/en/candel-therapeutics-to-present-at-september-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","CADL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661459492","title":"Has Candel Therapeutics (CADL) Run Too Far Ahead On Widening Losses?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661459492","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661459492?lang=en_us&edition=fundamental","pubTime":"2026-08-24 02:21","pubTimestamp":1787509270,"startTime":"0","endTime":"0","summary":"Candel Therapeutics (CADL) is back in focus after reporting second quarter 2026 results that showed a net loss of US$38.91 million. This compared with net income for the first half of 2025.\nSee our latest analysis for Candel Therapeutics.\nThe earnings release has come alongside strong momentum in Candel Therapeutics' stock, with a 1 month share price return of 37.34% and a year to date share price return of 141.36%. The 3 year total shareholder return is very large at around 9x, suggesting...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cadl/candel-therapeutics/news/has-candel-therapeutics-cadl-run-too-far-ahead-on-widening-l","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cadl/candel-therapeutics/news/has-candel-therapeutics-cadl-run-too-far-ahead-on-widening-l","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4539","BK4139","CADL","DCF","BK4585","BK4588","SPHQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473132","title":"Candel Therapeutics CTO Seshu Tyagarajan Sells 7,000 Shares for $84,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473132","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473132?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:31","pubTimestamp":1787171463,"startTime":"0","endTime":"0","summary":"Candel Therapeutics CTO Seshu Tyagarajan sells 7,000 shares for $84,000Candel Therapeutics CTO Seshu Tyagarajan sold 7,000 common shares on Aug. 17, 2026 at $12.Holdings fell to 76,865 shares followin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL7fp7Hy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Candel Therapeutics CTO Seshu Tyagarajan Sells 7,000 Shares for $84,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CADL","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659612540","title":"Candel Therapeutics is Maintained at Neutral by B of a Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2659612540","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659612540?lang=en_us&edition=fundamental","pubTime":"2026-08-15 02:33","pubTimestamp":1786732380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CADL/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CADL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659214005","title":"Analysts Are Bullish on Top Healthcare Stocks: Candel Therapeutics (CADL), Acurx Pharmaceuticals (ACXP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659214005","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659214005?lang=en_us&edition=fundamental","pubTime":"2026-08-14 23:10","pubTimestamp":1786720209,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Candel Therapeutics (CADL), Acurx Pharmaceuticals (A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-candel-therapeutics-cadl-acurx-pharmaceuticals-acxp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-candel-therapeutics-cadl-acurx-pharmaceuticals-acxp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4563","ACXP","BK4139","CADL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659214639","title":"BofA Adjusts Price Target on Candel Therapeutics to $12 From $9","url":"https://stock-news.laohu8.com/highlight/detail?id=2659214639","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659214639?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:40","pubTimestamp":1786707609,"startTime":"0","endTime":"0","summary":"Candel Therapeutics (CADL) has an average rating of buy and mean price target of $20.88, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CADL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659691971","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxis Oncology (PYXS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659691971","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659691971?lang=en_us&edition=fundamental","pubTime":"2026-08-14 01:20","pubTimestamp":1786641612,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-candel-therapeutics-cadl-lensar-lnsr-and-pyxis-oncology-pyxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-candel-therapeutics-cadl-lensar-lnsr-and-pyxis-oncology-pyxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","HCSG","LU0029874061.USD","BK4581","LNSR","CADL","XBI","LABU","PYXS","BK4139","BK4137","BK4082","BK4585","BK4539","LU0128526141.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659716615","title":"Candel Therapeutics Price Target Maintained with a $23.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2659716615","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659716615?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:17","pubTimestamp":1786637820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CADL/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CADL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659059150","title":"Candel Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659059150","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659059150?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:59","pubTimestamp":1786629541,"startTime":"0","endTime":"0","summary":"Candel Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryCandel Therapeutics IncCADL.OQreported a quarterly adjusted loss of 52 cents per share for the quarter ended Jun","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL8N44A1GA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","CADL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659400154","title":"Earnings Flash (CADL) Candel Therapeutics Posts Q2 Net Loss $0.52 a Share, vs. FactSet Est of $0.21 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2659400154","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659400154?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:24","pubTimestamp":1786623868,"startTime":"0","endTime":"0","summary":"Earnings Flash (CADL) Candel Therapeutics Posts Q2 Net Loss $0.52 a Share, vs. FactSet Est of $0.21 Loss","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CADL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659154315","title":"Candel Therapeutics: Q2 EPS $-0.52","url":"https://stock-news.laohu8.com/highlight/detail?id=2659154315","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659154315?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:09","pubTimestamp":1786622953,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nPLXZVK227:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CADL","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659154357","title":"Candel Therapeutics Q2 FY26 Net Loss Widens to $38.9 Million; R&D Expense More than Doubles to $19.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659154357","media":"Reuters","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659154357?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:08","pubTimestamp":1786622901,"startTime":"0","endTime":"0","summary":"Candel Therapeutics Q2 FY26 net loss widens to $38.9 million; R&D expense more than doubles to $19.8 millionCandel Therapeutics posted a Q2 2026 net loss of USD 38.9 million, widening from a loss of U","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL5Gbb6F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","CADL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659154893","title":"Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2659154893","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659154893?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:05","pubTimestamp":1786622700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUAKTLSS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","CADL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658822934","title":"Candel Therapeutics Inc Expected to Post a Loss of 24 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658822934","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658822934?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:39","pubTimestamp":1786369149,"startTime":"0","endTime":"0","summary":"Candel Therapeutics Inc <CADL.OQ> expected to post a loss of24cents a share - Earnings PreviewCandel Therapeutics IncCADL.OQCADL.Ois expected to  show no change in quarterly revenue when it reports  r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N447177:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CADL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656301301","title":"Candel Therapeutics Grants Inducement Stock Options for 30,800 Shares at $10.01 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2656301301","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656301301?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:05","pubTimestamp":1785787545,"startTime":"0","endTime":"0","summary":"Candel Therapeutics grants inducement stock options for 30,800 shares at $10.01 eachCandel Therapeutics granted stock options covering 30,800 common shares to three new employees on July 31, 2026.Opti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDLQsHcY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","BK4585","NDAQ","IE00BN0W2T93.GBP","BK4588","SG9999014039.USD","IE00B64PRP62.GBP","LU2210149790.SGD","BK4112","SG9999014013.SGD","LU0314104364.USD","CADL","BCDF","IE00BKPKM429.USD","BK4539","LU2210150020.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","LU2095319765.USD","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656030200","title":"Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656030200","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656030200?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:05","pubTimestamp":1785787500,"startTime":"0","endTime":"0","summary":"NEEDHAM, Mass., Aug.  03, 2026  (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immuno","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/03/3337872/0/en/Candel-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","CADL","LCLG"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.candeltx.com","stockEarnings":[{"period":"1week","weight":-0.0222},{"period":"1month","weight":0.2218},{"period":"3month","weight":0.5018},{"period":"6month","weight":1.587},{"period":"1year","weight":1.6108},{"period":"ytd","weight":1.2619}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0005},{"period":"3month","weight":0.0443},{"period":"6month","weight":0.1455},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1294}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. It develops CAN-2409, which is in Phase II clinical trials for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma. The company also develops CAN-3110, which is in Phase I clinical trials for the treatment of recurrent high-grade glioma. It also develops the?enLIGHTEN Discovery Platform, a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. Candel Therapeutics, Inc. was incorporated in 2003 and is headquartered in Needham, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.056687},{"month":2,"riseRate":0.4,"avgChangeRate":0.052018},{"month":3,"riseRate":0.2,"avgChangeRate":-0.120448},{"month":4,"riseRate":0.4,"avgChangeRate":0.650234},{"month":5,"riseRate":1,"avgChangeRate":0.18781},{"month":6,"riseRate":0.2,"avgChangeRate":-0.088023},{"month":7,"riseRate":0.2,"avgChangeRate":0.003189},{"month":8,"riseRate":0.833333,"avgChangeRate":0.108437},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.017906},{"month":10,"riseRate":0.4,"avgChangeRate":-0.110246},{"month":11,"riseRate":0,"avgChangeRate":-0.079739},{"month":12,"riseRate":0.8,"avgChangeRate":0.288433}],"exchange":"NASDAQ","name":"Candel Therapeutics, Inc.","nameEN":"Candel Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Candel Therapeutics, Inc.(CADL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Candel Therapeutics, Inc.(CADL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Candel Therapeutics, Inc.,CADL,Candel Therapeutics, Inc.股票,Candel Therapeutics, Inc.股票老虎,Candel Therapeutics, Inc.股票老虎国际,Candel Therapeutics, Inc.行情,Candel Therapeutics, Inc.股票行情,Candel Therapeutics, Inc.股价,Candel Therapeutics, Inc.股市,Candel Therapeutics, Inc.股票价格,Candel Therapeutics, Inc.股票交易,Candel Therapeutics, Inc.股票购买,Candel Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Candel Therapeutics, Inc.(CADL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Candel Therapeutics, Inc.(CADL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}